IP Library › Granted Patent US 7,342,100
Granted Patent B2
US 7,342,100 · App. 10/860,649 · Granted Mar 11, 2008

Hpr6 mutants and uses thereof

Assignee: University of Kentucky Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,342,100
App. No.
10/860,649
Granted
Mar 11, 2008
Kind
B2
Abstract

Methods and agents that interfere with Hpr6 function in non-sarcoma tumor cells are disclosed. Anti-Hpr6 agents are used to enhance the killing effect of anti-cancer agents in non-sarcoma tumor cells and to teat non-sarcoma tumors.

Claims (1)

1. An isolated polypeptide having the amino acid sequence of SEQ ID NO:11.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Jul 13, 2021
From: UNITED STATES OF AMERICA; ORGANIZATION - WORLD INTELLECTUAL PROPERTY
To: ORGANIZATION - WORLD INTELLECTUAL PROPERTY
Reel/Frame 056842/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2004
From: CRAVEN, ROLF JOSEPH
To: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Reel/Frame 016089/0478 →
Continuity (1)
Related Publication 20050272045A1 · Dec 8, 2005